- Report
- November 2023
- 90 Pages
United States
From €3358EUR$3,500USD£2,904GBP
- Report
- April 2023
- 144 Pages
Global
From €2830EUR$2,950USD£2,448GBP
- Report
- April 2023
- 120 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- April 2023
- 86 Pages
Europe
From €4222EUR$4,400USD£3,651GBP
- Report
- April 2020
- 113 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,277GBP
Sarcoma is a type of cancer that affects the connective tissues of the body, such as muscle, bone, fat, and blood vessels. Sarcoma drugs are used to treat this type of cancer, and are part of the larger oncology drug market. These drugs are typically used in combination with other treatments, such as surgery, radiation, and chemotherapy. Sarcoma drugs are designed to target the specific type of cancer, and can be used to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of metastasis.
The sarcoma drug market is highly competitive, with many companies developing new treatments and therapies. Some of the major players in the market include Pfizer, Merck, Novartis, Bristol-Myers Squibb, and Eli Lilly. Other companies, such as Amgen, AstraZeneca, and Celgene, are also developing treatments for sarcoma. Show Less Read more